Evaluation of the Effectiveness of Virtual Reality as an Adjunct to Standard Care in Managing Perioperative Anxiety and Pain in Patients Undergoing Lower Limb Orthopedic Surgery Under Spinal Anesthesia
1 other identifier
interventional
120
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether virtual reality (VR) can effectively reduce perioperative anxiety and pain in patients undergoing lower limb orthopedic surgery under spinal anesthesia. The study focuses on adult patients in a surgical setting, with an emphasis on improving intraoperative experience and postoperative outcomes without relying solely on pharmacological interventions. The main questions it aims to answer are:
- Can VR reduce perioperative anxiety and perceived pain levels?
- Does the use of VR lower the need for sedative and analgesic medications and improve hemodynamic stability and satisfaction? Researchers will compare a VR intervention group to a standard care group to see if VR leads to reduced anxiety and pain, less medication use, better physiological stability, and improved satisfaction. Participants will:
- Undergo orthopedic surgery under spinal anesthesia.
- Be randomly assigned to either receive standard perioperative care or standard care plus VR immersion.
- In the VR group, engage in calming, immersive virtual environments during the perioperative period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedFirst Submitted
Initial submission to the registry
August 7, 2025
CompletedFirst Posted
Study publicly available on registry
August 21, 2025
CompletedAugust 21, 2025
August 1, 2025
10 months
August 7, 2025
August 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact of Immersive Virtual Reality on Reducing Perioperative Anxiety in Lower Limb Orthopedic Surgery Under Spinal Anesthesia
The inversigator expect that the use of immersive virtual reality (VR) during lower limb orthopedic surgery under spinal anesthesia will: Significantly reduce perioperative anxiety levels compared to standard care
pre during the intervention and post-intervention
Secondary Outcomes (1)
The Effect of Virtual Reality on Perioperative Pain, Sedative Use, and Patient Satisfaction in Orthopedic Surgery Under Spinal Anesthesia
pre during the intervention and post-intervention
Study Arms (2)
VR group
EXPERIMENTALParticipants in the experimental group will receive an immersive virtual reality (VR) session as an adjunct to standard perioperative care. A SHINECON VR headset will be used to deliver calming or distraction-based visual and auditory content during the entire duration of the orthopedic surgery under spinal anesthesia. The session aims to reduce anxiety and pain perception, minimize the need for sedatives and analgesics, enhance hemodynamic stability, and improve patient and healthcare team satisfaction.
T group
NO INTERVENTIONParticipants in the control group will receive standard perioperative care as per institutional protocol during orthopedic surgery under spinal anesthesia. No virtual reality device or additional non-pharmacological intervention will be administered. Anxiety, pain, hemodynamic stability, sedative and analgesic use, and satisfaction will be evaluated and compared to the experimental group.
Interventions
Patients included in the intervention group (VR group) participated in a comprehensive virtual reality program designed to reduce perioperative anxiety and pain. Prior to their surgery, they attended an introductory VR session aimed at familiarizing them with the technology and providing a calming, immersive environment to help alleviate preoperative stress. Throughout their surgical journey, these patients continued to receive the usual standard care, which included thorough preoperative consultations with healthcare providers, detailed information about the planned surgical procedure, and the provision of standard postoperative care to support recovery. Additionally, during the surgery itself, patients underwent a VR session delivered via a headset, offering real-time immersive distraction and relaxation to minimize intraoperative anxiety and pain perception.
Eligibility Criteria
You may qualify if:
- Age between 19 and 64 years
- American Society of Anesthesiologists (ASA) physical status classification I or II (Annex 1)
- Scheduled for lower limb orthopedic surgery under spinal anesthesia
- Provided informed consent to participate in the study
- Patient refusal to participate in the study
- Contraindications to virtual reality (VR) (Patients with cognitive or psychiatric disorders, Claustrophobia, Uncontrolled epilepsy, Visual and/or auditory impairments preventing the use of VR)
- Contraindications to midazolam: known hypersensitivity to benzodiazepines or any excipient of the product
- Patients currently taking anxiolytic medications
- Contraindications to regional anesthesia (spinal anesthesia), (Coagulation disorders, Shock or uncompensated hypovolemia, Unstable arterial hypertension, Decompensated heart failure, Severe aortic or mitral stenosis, Intracranial hypertension, Infection near the puncture site, Progressive neurological disorders, Allergy to local anesthetics, Technical difficulties in performing spinal anesthesia)
You may not qualify if:
- Failure of spinal anesthesia requiring conversion to general anesthesia
- Occurrence of an anesthetic or surgical complication
- Occurrence of an adverse effect related to virtual reality, such as (Dizziness, Ocular or muscular contractions triggered by light stimulation, Signs of discomfort : eye strain, blurred vision, disorientation, imbalance, anxiety attack, headache, nausea, vomiting)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Habib Bourguiba University Hospital
Sfax, 3000, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Imen Zouche, Professor in Medicine
University of Sfax
- STUDY DIRECTOR
Yosra Mejdoub, Professor in Medicine
University of Sfax
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
August 7, 2025
First Posted
August 21, 2025
Study Start
September 1, 2024
Primary Completion
June 30, 2025
Study Completion
July 30, 2025
Last Updated
August 21, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- When the investigator Publish the Study Article and When the investigator finish Doctoral Studies
- Access Criteria
- Researchers who may need this data for future studies